Technology in Perspective 12.30.23 | New era: CRISPR's medicine 💊
The gene-editing technology CRISPR has been used to change the genes of human babies, to modify animals, to treat people with sickle-cell disease, and possibly to permanently cure people of HIV. And Vertex Pharmaceuticals that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking for an ordinary drug that could take its place.
Plus, navigate the future of technology with confidence with our year end offer: 25% off on annual subscription. Subscribe & save 25% today.
The company will pay rival Editas Medicine and the Broad Institute so that it can sell its breakthrough gene-editing treatment for sickle-cell disease.
The disease kills millions of birds each year, and it has recently started to spread among mammals too.
Make 2024 the year your keep up with the fast-paced world of technological innovations and their impact on the way you live and work. Subscribe today to save 25% on an annual subscription to MIT Technology Review.
Comments
Post a Comment